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OBJECTIVE—Transgenic expression of diacylglycerol acyltrans-
ferase-1 (DGAT1) in skeletal muscle leads to protection against
fat-induced insulin resistance despite accumulation of intramuscu-
lar triglyceride, a phenomenon similar to what is known as the
“athlete paradox.” The primary objective of this study is to deter-
mine how DGAT1 affects muscle fatty acid oxidation in relation to
whole-body energy metabolism and insulin sensitivity.
RESEARCH DESIGN AND METHODS—We ﬁrst quantiﬁed
insulin sensitivity and the relative tissue contributions to the
improved whole-body insulin sensitivity in muscle creatine
kisase (MCK)-DGAT1 transgenic mice by hyperinsulinemic-eu-
glycemic clamps. Metabolic consequences of DGAT1 overexpres-
sion in skeletal muscles were determined by quantifying
triglyceride synthesis/storage (anabolic) and fatty acid oxidation
(catabolic), in conjunction with gene expression levels of repre-
sentative marker genes in fatty acid metabolism. Whole-body
energy metabolism including food consumption, body weights,
oxygen consumption, locomotor activity, and respiration ex-
change ratios were determined at steady states.
RESULTS—MCK-DGAT1 mice were protected against muscle
lipoptoxicity, although they remain susceptible to hepatic lipotox-
icity. While augmenting triglyceride synthesis, DGAT1 overexpres-
sion also led to increased muscle mitochondrial fatty acid oxidation
efﬁciency, as compared with wild-type muscles. On a high-fat diet,
MCK-DGAT1 mice displayed higher basal metabolic rates and
5–10% lower body weights compared with wild-type littermates,
whereas food consumption was not different.
CONCLUSIONS—DGAT1 overexpression in skeletal muscle led
to parallel increases in triglyceride synthesis and fatty acid oxida-
tion. Seemingly paradoxical, this phenomenon is characteristic of
insulin-sensitive myoﬁbers and suggests that DGAT1 plays an active
role in metabolic “remodeling” of skeletal muscle coupled with
insulin sensitization. Diabetes 58:2516–2524, 2009
D
espite the observation that higher fat content in
skeletal muscle is associated with insulin resis-
tance as commonly seen in obesity and type 2
diabetes, increased muscle fat content is also
associated with exercise training, in which it is “paradox-
ically” coupled with enhanced insulin sensitivity (the
“athlete paradox”) (1–3). In fact, higher fat content is also
seen in “oxidative” (with greater fatty acid oxidation
capacity), slow-twitch type I myoﬁbers compared with
“glycolytic,” fast-twitch type II myoﬁbers. Interestingly,
type I myoﬁbers appear to be inherently more insulin
sensitive than type II myoﬁbers (4). In human skeletal
muscle, insulin-stimulated glucose transport directly cor-
relates with the percentage of oxidative type I myoﬁbers
(5–7). Furthermore, exercise enhances muscle insulin
sensitivity and is associated with increased muscle fat
content and/or mitochondrial fatty acid oxidation capacity
(1,3,8,9). In contrast, a decrease in oxidative, and con-
versely an increase in glycolytic, capacity is characteristic
of skeletal muscle seen in sedentary obese individuals
(10,11).
Exercise increases myocytic diacylglycerol acyltrans-
ferase (DGAT) activity, and transgenic overexpression of
DGAT1 in skeletal muscle in mice is sufﬁcient to replicate
the exercise paradox characterized by increased muscle
fat content coupled with increased muscle insulin sensi-
tivity (3). Exercise also increases skeletal muscle DGAT1
expression and improves insulin sensitivity in humans
(12). DGAT1 catalyzes the last step of triglyceride synthe-
sis from diacylglyerol (DAG) and fatty acyl-CoA. By chan-
neling fatty acid substrates into the triglyceride synthesis
pathway, DGAT1 effectively decreases levels of muscle
DAG and ceramide (3), two fatty acid derivatives that are
believed to be causative in the development of obesity-
related insulin resistance (3,13–17). In sedentary humans
or rodents with fat-induced insulin resistance, higher muscle
triglyceride content is also associated with elevated myo-
cytic DAG and/or ceramide levels as a result of fatty acid
overload (12,13,15); lipid metabolites and storage products
are both increased in this substrate-driven process. In-
creased fatty acid load and consequent increases in in-
tramyocellular fatty acid metabolites are lipotoxic and
cause muscle insulin resistance (18). Increased myocytic
DAG, for example, causes insulin resistance via activation
of protein kinase C (13,14) leading to serine phosphory-
lation of insulin receptor substrate (IRS)-1 (13). Thus,
while increased DAG is causal, high myocytic triglyceride-
content is not always a marker for muscle insulin resis-
tance, as long as lipotoxic fatty acid metabolites are kept
at low levels (3).
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stores and fatty acid oxidation activity as exempliﬁed by
oxidative type I myoﬁbers or the exercise-trained muscle
model, we hypothesized that triglyceride synthesis and
fatty acid oxidation capacities are intrinsically intercon-
nected and both are upregulated in insulin-sensitive mus-
cles. The present study demonstrates upregulation of both
triglyceride synthesis and fatty acid oxidation capacities in
the insulin-sensitive, DGAT1 overexpressing muscle model.
This study also suggests that DGAT1 overexpression is a
cause of such a “paradoxical” change in fat metabolism.
We postulate that this coordinated change enables the
myocytes to keep the intracellular levels of fatty acid
metabolites below a potentially lipotoxic level. By chan-
neling lipotoxic fatty acid metabolites into storage (as
triglyceride) and into a pathway for terminal oxidation,
such a change may lessen fatty acid–induced insulin
resistance that is often associated with acquired obesity
(3,12,13,19).
RESEARCH DESIGN AND METHODS
Mice, diets, and exercise. MCK-DGAT1 transgenic mice and wild-type
littermates were fed standard rodent diet or high-fat diet (HFD) as previously
described (3). The swimming exercise regimen was the same as described (3).
Male mice were used in this study. Animal protocols were approved by the
Columbia University Institutional Animal Care and Use Committee.
Hyperinsulinemic-euglycemic clamps. Three-month-old mice were fed
HFD or standard rodent diet for 8 weeks before the clamp study. The clamp
was conducted in awake mice as previously described (19). All procedures
were approved by the Yale University Institutional Animal Care and Use
Committee. Brieﬂy, after an overnight fast, [3-
3H]-glucose (high-performance
liquid chromatography puriﬁed; Perkinelmer) was infused at 0.05 Ci/min for
2 h to assess the basal glucose turnover. Hyperinsulinemic-euglycemic clamp
was conducted for 120 min with primed/continuous infusion of human insulin
(Novo Nordisk; 105 pmol/kg prime, 15 pmol  kg
1  min
1 infusion), keeping
plasma glucose at 6.7 mmol/l (basal level). [3-
3H]-glucose was infused at 0.1
Ci/min throughout the clamp to estimate insulin-stimulated whole-body
glucose ﬂuxes. Calculations of hepatic glucose output (HGO), whole-body
glycolysis, and whole-body glycogen synthesis were also as described (20). To
assess muscle glucose uptake, separate groups of mice were clamped and
2-deoxy-D-[1-
14C]glucose (2-[
14C]DG; Perkinelmer) was injected as a bolus at
the 75th min of the clamp as described (20).
Mitochondrial fatty acid oxidation. Four-month-old mice pretreated with
HFD for 8 weeks were used for these experiments. Mitochondria were
isolated from muscle tissues using Mitochondria Isolation Kits (Sigma-
Aldrich, St. Louis, MO) according to the manufacturer’s instructions. Mito-
chondrial fatty acid oxidation was performed by measuring the rate of
3H2O
production from the substrate [
3H]palmitate present in excess (ﬁnal concen-
trations: 0.2 mmol/l palmitate with 10 Ci/ml of 9,10(n)-[
3H]palmitate and
1.25% BSA) in a mitochondria incubation medium (containing 20 g mito-
chondria protein) as described (21).
Mitochondrial DNA copy number, ATP production rate, citrate syn-
thase, -hydroxyacyl-CoA dehydrogenase, and carnitine palmitoyl
transferase I activities. Four-month-old mice pretreated with HFD for 8
weeks were used for these experiments. Mitochondrial DNA copy number was
measured using quantitative real-time PCR as previously described (22).
Mitochondrial DNA for NADH dehydrogenases 1 and 4 (ND1 and ND4) and
nuclear DNA for -actin were coampliﬁed within the same reaction wells (for
primer sequences, see supplemental Table 1, available in an online appendix
at http://diabetes.diabetesjournals.org/cgi/content/full/db08-1096/DC1). Mito-
chondrial ATP production rates were measured in isolated mitochondria
through time-course monitoring of bioluminescence in response to a luciferin-
luciferase ATP-monitoring reagent (Biotherma, Haninge, Sweden) as de-
scribed (23). Maximal activity of citrate synthase was measured in muscle
homogenates by photospectrometry as described (24). -hydroxyacyl CoA
dehydrogenase (HAD) activity was also measured in muscle homogenates by
following spectrophotometrically the conversion of acetoacetyl-CoA to -hy-
droxybutyryl-CoA by -HAD as described (25). Total carnitine palmitoyl
transferase (CPT) activity was assayed radiochemically in isolated mitochon-
dria by following the conversion of palmitoyl-L-carnitine from palmitoyl-CoA
and radiolabeled L-carnitine as described (25,26). CPT-I activity was calcu-
lated from the total CPT activity after subtraction of CPT-II activity, which
was measured in the presence of 0.2 mmol/l malonyl-CoA that inhibits CPT-I.
Transmission electron microscopy. Four-month-old mice pretreated with
HFD for 8 weeks were used. Muscles were isolated, ﬁxed with 2.5% glutaral-
dehyde in 0.1M Sorenson’s buffer (PH 7.2), and treated with 1% OsO4 also in
Sorenson’s buffer for 1 h. After dehydration and embedment in Lx-112 (Ladd
Research Industries), thin sections (60 nm) were cut using a MT-7000
ultramicrotome, stained with uranyl acetate and lead citrate, and examined
under a JEOL JEM-1200 EXII electron microscope. Pictures were captured by
an ORCA-HR digital camera (Hamamatsu) and recorded with an AMT Image
Capture Engine.
Indirect calorimetry. Twenty-week-old weight-matched male MCK-DGAT1
mice and wild-type littermates that had been on a HFD for 8 weeks were singly
housed in metabolic chambers. After 2–4 days of adaptation, oxygen con-
sumption, locomotor activity, and respiration exchange ratio were measured
continuously over at least 5 days during 12:12 light-dark cycles, using a CLAMS
(Columbus Instruments, Columbus, OH) open-circuit indirect calorimetry
system as previously described (27).
RT-PCR, Western blot, DGAT activity, and triglyceride contents. Four-
month-old mice with 8-week HFD pretreatment were used for these experi-
ments. RT-PCR (3,28) and Western blot (3,29) were as described. Gene-
speciﬁc primer sets are listed in supplemental Table 1. Primary antibodies to
pyruvate dehydrogenase kinase (PDK)4, uncoupling protein (UCP)-3, CD36,
and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) were obtained
from Abcam (Cambridge, MA). DGAT activity was measured in vitro using
[
14C]-labeled palmitoyl-CoA as previously described (29,30). The method to
quantify muscle triglyceride content was as described (3,29).
Statistical analysis. Statistical differences were ﬁrst analyzed by ANOVA to
determine overall treatment effects (genotype or exercise), followed by post
hoc comparisons between concerned study groups (Statistica V6.0, StatSoft,
OK). A two-tailed P value of 0.05 was used to indicate statistical signiﬁcance.
For indirect calorimetry measurements, ANOVA repeated measures (Prism,
GraphPad Software, San Diego, CA) were used. Post hoc analyses were
conducted using Tukey post hoc or Bonferroni comparisons. Data are
expressed as means  SE.
RESULTS
MCK-DGAT1 transgenic mice demonstrate improved
resistance to diet-induced lipotoxicity, but they re-
main susceptible to hepatic insulin resistance on
HFD. Using glucose tolerance and insulin tolerance tests,
we showed previously that MCK-DGAT1 mice were pro-
tected against HFD-induced insulin resistance (3). Ex vivo
2-deoxyglucose uptake in skeletal muscles isolated from
HFD-fed animals demonstrated that insulin sensitivity
was greater in DGAT1-overexpressing muscles than in
the wild-type muscles (3). In this study, whole-body and
tissue insulin sensitivities were assessed in vivo by
hyperinsulinemic-euglycemic clamps in combination
with radioisotope-labeled glucose infusions. Three-
month-old male MCK-DGAT1 and wild-type mice were fed
HFD for 8 weeks (WT-HF and DGAT1-HF, respectively)
before the clamp study. Age- and sex-matched wild-type
mice on standard rodent diet (WT-NC) were used as
baseline control. The major ﬁndings are depicted in Fig. 1,
and other energetic and clamp parameters are summarized
in supplemental Table 2. As expected, WT-HF mice
showed marked insulin resistance with the mean whole-
body glucose infusion rate at only 16 mg  kg
1  min
1
(Fig. 1A). DGAT1-HF mice were more insulin sensitive
than WT-HF mice, achieving a mean whole-body glucose
infusion rate of 29 mg  kg
1  min
1 (Fig. 1A). However,
the baseline whole-body glucose infusion rate in the
control WT-NC mice was 45 mg  kg
1  min
1 (Fig. 1A),
indicating that DGAT1 overexpression provided 45%
protection against HFD-induced insulin resistance. Trans-
genic mice were not protected from HFD-induced hepatic
insulin resistance. Compared with a 50% suppression
of HGO in WT-NC mice during the clamping, insulin-
mediated suppression of HGO was completely absent in
both WT-HF and DGAT1-HF mice (Fig. 1B). To directly
assess muscle insulin sensitivity under the same clamping
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14C]glucose
was given. Uptake of 2-deoxy-D-[1-
14C]glucose in skeletal
muscle was 30% greater in DGAT1-HF mice than in
WT-HF mice (Fig. 1C), conﬁrming that increased lipotox-
icity tolerance in skeletal muscle was the physiological
basis for the protection of MCK-DGAT1 mice, albeit in-
complete, against HFD-induced whole-body insulin
resistance.
DGAT1 overexpression in skeletal muscle leads to
improved mitochondrial fatty acid oxidation efﬁ-
ciency as well as increased triglyceride synthesis and
storage. As expected, muscle DGAT activity was three-
fold increased in MCK-DGAT1 (Fig. 2A), which was asso-
ciated with a 70% increase in muscle triglyceride content
(Fig. 2B). To characterize skeletal muscle fatty acid oxi-
dation capacity, we ﬁrst determined mitochondrial DNA
(mtDNA) copy number by assessing the ratio of mtDNA
ND1 and ND4 to the nuclear DNA -actin gene in soleus
and anterior tibial muscles. There were 30–45% fewer
mitochondria per copy genome DNA in DGAT1-overex-
pressing tibial and soleus muscles than those of the
wild-type controls (Fig. 2C). However, analyses of mito-
chondrial ATP production rates (MAPR) per unit muscle
protein revealed no reduction in transgenic mice as com-
pared with wild-type mice (Fig. 2D). Maximal tissue citrate
synthase activity was signiﬁcantly greater in the DGAT1-
overexpressing soleus muscle than the wild-type counter-
part was, although no signiﬁcant difference was detected
in tibialis anterior (Fig. 2D). Maximal tissue -HAD activity
per unit muscle protein was signiﬁcantly greater in the
transgenic muscle than the wild-type muscle (Fig. 2E).
Similarly, mitochondrial CPT-I activity per unit mitochon-
drial protein was signiﬁcantly greater in the DGAT1-
overexpressing muscle than the wild-type muscle (Fig.
2E). The unchanged or potentially enhanced mitochon-
drial oxidative capacity in the presence of fewer mitochon-
dria suggested a higher mitochondrial efﬁciency in
DGAT1-overexpressing muscles. Direct examination of so-
leus muscles by electron microscopy conﬁrmed that fewer,
but bigger, mitochondria were present in the DGAT1-
overexpressing muscle (Fig. 2F) than in the wild-type
muscle (Fig. 2G). Additionally, in vitro measurement of
maximal fatty acid oxidation rates demonstrated a 20%
increase in fatty acid oxidation capacity in the MCK-
DGAT1 muscle compared with the wild-type muscle (1,217
vs. 1,019 nmol  min
1  g
1 mitochondrial protein, P 
0.01; Fig. 2H).
Upregulation of PDK4 and UCP3 in skeletal muscle of
MCK-DGAT1 transgenic mice. mRNA levels of marker
genes in fat metabolism were examined by real-time PCR
in soleus muscle from 4-month-old male wild-type and
MCK-DGAT1 transgenic mice after 8-week HFD feeding
(Fig. 3A). DGAT1 mRNA levels were approximately three-
fold as high in MCK-DGAT1 mice as in wild-type mice (P 
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FIG. 1. Whole-body, hepatic, and muscle insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp. A: Steady-state whole-body glucose
infusion rates in age-, sex-, genetic background–, and breeding environment–matched wild-type mice on standard rat diet (WT-NC), wild-type mice
pretreated with ad lib HFD feeding for 8 weeks (WT-HF), and MCK-DGAT1 mice pretreated with ad lib HFD feeding for 8 weeks (DGAT1-HF).
B: Steady-state HGO before (basal HGO) and after (clamp HGO) insulin infusion at the rate of 3 mU  kg
1  min
1 in WT-NC, WT-HF, and
DGAT1-HF mice under the same clamp conditions as in A. C: 2-Deoxyglucose uptake in skeletal muscle after bolus injection of the [
14C]-labeled
2-deoxyglucose under the same clamp conditions as in A and B. Data are presented as means  SE; P and n are as indicated; *P < 0.05. 2-DG,
2-deoxyglucose.
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were doubled in MCK-DGAT1 compared with wild-type
mice (P  0.05). There was also a trend of approximate
doubling of mRNA levels for CD36 (P 	 0.051), CPT1 (P 	
0.120), ACC2 (P 	 0.072), and GLUT4 (P 	 0.117) in
MCK-DGAT1 mice. No signiﬁcant changes were detected
in mRNA levels for DGAT2, fatty acids, ACS1, ADRP,
sterol regulatory element–binding protein-1c, peroxisome
proliferator–activated receptor (PPAR)-
, PPAR, PPAR,
peroxisome proliferator–activated receptor  coactiva-
tor-, CRAT, ECHS1, UCP1, UCP2, and PEPCK.
PDK4 is believed to play a critical role in regulating the
fuel partitioning between fat and glucose oxidation
(31,32). To further understand the changes in PDK4 ex-
pression in MCK-DGAT1 muscles, we compared a group of
DGAT1-overexpressing mice with a group of wild-type
0
1
2
3 WT
Dgat1
WT
Dgat1
WT
Dgat1
WT
Dgat1
0
4
8
12
ND1 ND4 ATP CS 
m
t
D
N
A
/
a
c
t
i
n
 
D
N
A
 
C
S
 
(
m
m
o
l
/
m
i
n
/
g
)
30
0
30
0
0
0.3
0.3
0
M
A
P
R
 
(
µ
m
o
l
/
m
i
n
/
g
)
β
-
H
A
D
 
(
m
m
o
l
/
m
i
n
/
g
)
T
i
b
i
a
l
S
o
l
e
u
s
*
WT 
Dgat1
0.1
0
0.2
β-HAD CPT-1
C
P
T
-
1
 
(
n
m
o
l
/
m
i
n
/
g
)
20
10
0
0
3
6
9
12
15
  WT   Dgat1
0
5
10
15
20
25
    WT   Dgat1 
T
G
 
(
n
m
o
l
/
m
g
)
[
3
H
]
T
G
 
(
c
p
m
 
x
 
1
0
0
0
) DGAT activity (soleus) TG content (soleus) B A
E
C D
Soleus
M
A
P
R
 
(
µ
m
o
l
/
m
i
n
/
g
)
C
S
 
(
m
m
o
l
/
m
i
n
/
g
)
mtDNA copy number
EM-mitochondria EM-mitochondria
MAPR and CS
β-HAD and CPT-1
m
t
D
N
A
/
a
c
t
i
n
 
D
N
A
 
M
a
x
i
m
u
m
 
F
A
 
o
x
i
d
a
t
i
o
n
 
(
m
m
o
l
H
2
O
/
m
g
/
m
i
n
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
WT Dgat1 
**
M
a
x
i
m
u
m
 
F
A
 
o
x
i
d
a
t
i
o
n
 
(
m
m
o
l
H
2
O
/
m
g
/
m
i
n
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
WT Dgat1 
H G F
Soleus
** **
* *
*
*
**
**
**
Mt FA oxidation
WT-soleus Dgat1-soleus
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the wild-type and MCK-DGAT1 mice (n  6, each group). F and G: Representative low- and high-power (inserts) views of the electron microscopic
ﬁelds of the soleus muscle from the wild-type (F) and MCK-DGAT1 (G) mice. Quantiﬁcation of 6000 EM micrographs using an image analysis
system (Imagine-Pro Plus 5.0, Media Cybernetics) showed that wild-type and DGAT1 mice have 149  3.6 and 98  7.7 mitochondria per 10  10
micron muscle area, respectively (P < 0.001). The average mitochondrial size is 34,432  4,246 pixels for wild-type and 62,418  938 pixels for
DGAT1 mice (P  0.014). H: Maximal mitochondrial fatty acid oxidation rates measured in isolated mitochondria of the soleus muscles from the
wild-type and MCK-DGAT1 mice (n  6, each group). Values are expressed as means  SE; NS, no statistical signiﬁcance (P > 0.05); *P < 0.05,
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wild-type mice as a baseline control, both DGAT1 overex-
pression and exercise led to 1.5-fold increases (P  0.05)
in PDK4 mRNA levels in skeletal muscle (Fig. 3B and C),
providing two independent cases in which upregulation
of PDK4 mRNA expression was dissociated from glu-
cose intolerance. Western blot of CD36, UCP3, and
PDK4 showed 1.4- to 1.8-fold increases of these proteins
in DGAT1-overexpressing muscle relative to wild-type
muscle (Fig. 3D).
MCK-DGAT1 mice display increased energy expendi-
ture without changes in food intake. To determine the
physiological signiﬁcance of the above in vitro ﬁndings
and to help interpret the physiological consequences of
the increased triglyceride synthesis and increased mito-
chondrial fatty acid oxidation capacity (and higher expres-
sion levels of the uncoupling protein UCP3) in DGAT1-
overexpressing skeletal muscle, we measured whole-body
energy metabolism in vivo. Four-month-old weight- and
adiposity-matched (Fig. 4A) male MCK-DGAT1 and wild-
type mice were analyzed in metabolic chambers after
8-week HFD feeding. MCK-DGAT1 mice appeared less
physically active than wild-type mice (Fig. 4B), although
the changes seemed to be unrelated to food-seeking behav-
ior, as food intake was the same between MCK-DGAT1 and
wild-type mice (Fig. 4G). In contrast to the changes in
physical activity, oxygen consumption rates were signiﬁ-
cantly higher in the transgenic mice than in wild-type mice
(Fig. 4C, wild-type vs. MCK-DGAT1, P  0.05, repeated-
measures ANOVA). No signiﬁcant difference was detected
in respiration exchange rates (RER) under these condi-
tions (Fig. 4D). Further experimental maneuver with two
consecutive 24-h measurements of VO2 during fasting
followed by refeeding revealed that the difference in
energy expenditure was accentuated during refeeding. As
expected, energy expenditure reduced and increased in
response to prolonged fast and refeeding, respectively, in
both wild-type and MCK-DGAT1 mice (Fig. 4E). However,
the increase during refeeding was markedly greater in the
transgenic mice than in wild-type mice (P  0.05, repeated-
measures ANOVA) (Fig. 4F). As was during regular ad lib
feeding, no difference in food intake was observed during
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type mice (Fig. 4G).
Long-term food intake was followed in mice fed a standard
rodent diet (total 11 weeks) or a HFD (total 8 weeks),
starting at 2 months of age. Periodic ﬂuctuations in food
intake were observed in both transgenic and wild-type
mice, more so in standard rodent diet–fed mice (Fig. 5A).
However, no difference was found between the two geno-
types either on standard rodent diet or on HFD (Fig. 5A
and B). A small but signiﬁcant body weight difference
(5–10%) was found between wild-type and MCK-DGAT1
mice on HFD, which became evident after 5 weeks of HFD
feeding and persisted throughout the remaining study
period (Fig. 5C). In the absence of reduced food intake or
increased physical activities, this ﬁnding indicates that
metabolic energy expenditure in DGAT1-HF mice was
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weight were observed between wild-type and MCK-DGAT1
mice on standard rodent diet (data not shown).
DISCUSSION
In this study, we ﬁrst demonstrated in vivo that although
skeletal muscle of MCK-DGAT1 mice was more resistant
to developing HFD-induced lipotoxicity, their liver was
as susceptible for lipotoxic insulin resistance as that of
wild-type mice. Under hyperinsulinemic-euglycemic clamp
conditions, MCK-DGAT1 mice were 45% protected
against HFD-induced insulin resistance at the whole-body
level compared with wild-type mice. The greater whole-
body insulin sensitivity in HFD-fed MCK-DGAT1 mice
(compared to HFD-fed wild-type mice) was associated
with 30% higher uptake of bolus-injected 2-deoxyglucose
in skeletal muscle under the same feeding and clamp
conditions, whereas insulin suppression of HGO was sim-
ilarly impaired in these mice, indicating that liver did not
contribute to the improved whole-body insulin sensitivity.
We showed that although triglyceride synthesis and
storage capacities were increased in DGAT1-overexpress-
ing muscle, mitochondrial fatty acid oxidation efﬁciency
was also improved. The latter was initially recognized by
decreased mitochondrial copy number in combination
with the uncompromised muscle citrate synthase activity
and increased maximal -HAD and CPT-I activities in
DGAT1-overexpressing muscles. This was then conﬁrmed
by increased maximal mitochondrial fatty acid oxidation
capacity per unit mitochondrial protein in DGAT1-overex-
pressing muscles. Interestingly, MAPR per unit mitochon-
drial proteins was similar in the two genotypes, suggesting
that the increased fatty acid oxidation efﬁciency does not
lead to increased energy efﬁciency. Gene expression levels
of muscle PDK4 and UCP3, normalized to -actin expres-
sion levels, were 100% greater in HFD-fed MCK-DGAT1
mice than in age-, sex-, and diet-matched wild-type mice.
Although increased PDK4 has been associated with greater
fuel partition into fatty acid oxidation (31,32), higher levels
of UCP3 may also signify increased use of fat as fuel
substrate and/or conversion of fat to thermal energy
(33,34). It is plausible that the lack of increase in MAPR in
DGAT1-overexpressing muscle, in the presence of in-
creased fatty acid oxidation rates, is because of increased
uncoupling of oxidative phosphorylation leading to in-
creased heat production. Although heat production was
not directly measured, whole-body 24-h VO2 production
rates were greater in DGAT1-HF than in WT-HF mice in
the absence of increased physical activity in the former.
The increased energy expenditure in MCK-DGAT1 mice
was further substantiated by the modest but signiﬁcant
lower body weight in the transgenic mice relative to
wild-type mice without any difference in energy intake;
long-term follow-up of the growth curve showed that
MCK-DGAT1 mice weighed 5–10% less than wild-type mice
on an at lib HFD feeding regimen, whereas food consump-
tion was the same in both groups. The reduced body
weight may contribute to the improved insulin sensitivity
shown in this study. However, the small weight difference
appears to result from changed fuel metabolism and is
unlikely a primary cause of the observed protection
against lipotoxicity. Marked differences in insulin sensitiv-
ity were seen between “weight-matched” wild-type and
MCK-DGAT1 mice and between isolated DGAT1 muscle
and wild-type muscle in ex vivo experiments, where
weight was not a factor (3).
Insulin resistance is associated with mitochondrial dys-
function in type 2 diabetes (23,35,36) and in the offspring
of parents with type 2 diabetes (37). Reduced mitochon-
drial function and insulin resistance occur in aging in
association with reduced mitochondrial DNA copy num-
ber (23). However, the issue regarding mitochondrial
deﬁciency and insulin resistance is unresolved (38). The
present study does not support the hypothesis that reduc-
tion in mitochondrial DNA copy number per se results in
insulin resistance. In our model, despite a reduction in
mitochondrial number, mitochondrial ATP production is
maintained (and heat production probably increased) be-
cause of increased fatty acid oxidation efﬁciency. These
ﬁndings suggest that mitochondrial quality is more critical.
In this regard, a recent study by Koves et al. demonstrated
that stressed mitochondria with greater but incomplete
fatty acid oxidation are only detrimental to insulin sensi-
tivity (39). The present study further suggests that greater
fatty acid oxidation capacity associated with increased
uncoupling activity may also be important in maintaining
insulin sensitivity. Of course, maintaining adequate oxida-
tive phosphorylation is necessary for muscle contractility,
particularly during exercise.
We have previously shown that skeletal muscle overex-
pressing DGAT1 behaved similarly to exercise-trained
muscle in that it had higher triglyceride content but was
more insulin sensitive, a phenomenon referred to as the
“athlete paradox” or “exercise paradox.” The decreased
myocytic DAG and ceramide levels with increased myo-
cytic triglyceride content are the expected effects of
DGAT1 actions (3). By converting fatty acyl-CoA and DAG
to triglyceride, DGAT1 is believed to be directly responsi-
ble for lowering the levels of the lipotoxic fatty acid
derivatives. The key ﬁnding of the present study is that
DGAT1-overexpressing muscle, like exercised muscle, had
increased fatty acid oxidation capacity, which was associ-
ated with increased steady-state metabolic rates at the
whole body level and a smaller HFD-induced weight gain
compared with wild-type mice. Importantly, because these
ﬁndings are made in the muscle-speciﬁc DGAT1 transgenic
mice, DGAT1 overexpression must be primarily responsi-
ble for these paradoxical changes. Because increased
DGAT1 expression is also observed with exercise, we
further postulate that DGAT1 may play a key mediatory
role in exercise-induced augmentation of both triglyceride
synthesis and, indirectly, mitochondrial fatty acid oxida-
tion. Together, the increased anabolic (triglyceride synthe-
sis/storage) and catabolic (fatty acid oxidation/degradation)
capacities may both help remove fatty acid intermediates
that can be overproduced during fatty acid overload.
Reducing intramyocellular DAG levels to below the
“threshold of lipotoxicity” is believed necessary to prevent
the induction of a cascade of signaling events including
activation of PKC isoforms and Jun NH2-terminal kinase-1
and inhibition of IRS-1, Akt, and GLUT4 in HFD-fed mice
(3).
Parallel upregulated triglyceride synthesis and fatty acid
oxidation seemed perplexing at the ﬁrst glance because
anabolic and catabolic pathways usually undergo changes
in the opposite directions, determined by cellular sub-
strate levels and energy status. However, examination of
typical myoﬁbers does show interdependency between the
two aspects of fatty acid metabolism: myoﬁbers that have
a high triglyceride content are typically the “oxidative”
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those with low triglyceride content (and high glycogen
content) are typically “glycolytic.” Importantly, compared
with glycolytic myoﬁbers, oxidative myoﬁbers with
greater capacities for triglyceride synthesis and fatty acid
oxidation appear to be intrinsically more insulin sensitive
(4). The present study provided an example of the “para-
doxical” coupling of lipid synthesis and oxidation in the
DGAT1-overexpressing muscles.
Clearly, these are not the usual reciprocal regulations of
the two aspects of the fatty acid metabolism driven by the
fatty acid substrate availability. DGAT1 overexpression in
skeletal muscle increased the capacities of both triglycer-
ide synthesis and fatty acid oxidation and enabled the
myocytes to endure fat overload without developing sig-
niﬁcant lipotoxicity or insulin resistance. However, instead
of increasing mitochondrial densities, DGAT1-overex-
pressing muscle appeared to have greater mitochondrial
fatty acid oxidation efﬁciency. Whether the improved fatty
acid oxidation is coupled with increased fatty acid trans-
port (as suggested by upregulation of CD36 and CPT-I)
and/or potentially increased de novo fatty acid synthesis
will require further investigation. A “futile cycle” of fatty
acid metabolism that consists of increased fatty acid
oxidation coupled with increased de novo fatty acid
synthesis has been proposed as a thermogenic mechanism
in muscle (40).
PDK is a key regulator of fuel partitioning between fatty
acid and glucose oxidation, and PDK4 is the major isoform
in muscle (41,42). PDK is acutely regulated, in general, by
small molecular effectors generated from fatty acid 
oxidation. Gene expression of PDK4 also responds to fuel
substrate availability and insulin levels (43–46). Addition-
ally, PDK4 gene expression appears to be modulated by
several more complex biological processes, such as insu-
lin resistance or exercise. Insulin resistance is generally
associated with upregulation of PDK4 (43,45), which may
be because of elevated fatty acid overload (47,48) or
deﬁcient/impaired insulin action (45,46,48). While promot-
ing muscle insulin sensitivity, exercise also “paradoxi-
cally” upregulates PDK4 gene expression in skeletal
muscle (49,50). Therefore, it appears that a different
mechanism for upregulating PDK4 is involved in exercise-
trained skeletal muscle and that this mechanism is not
substrate driven (49). Exercise upregulates PDK4 and fatty
acid oxidation but does not inhibit insulin-stimulated
glucose oxidation. In the present study, we showed that
DGAT1 overexpression produced a result similar to exer-
cise with regard to PDK4 upregulation, increased fatty
acid oxidation, and insulin sensitivity, suggesting that the
change in PDK4 expression in this model is also not a
secondary response to reduced insulin actions. It is cur-
rently unclear, in either the exercise model or the DGAT1-
overexpression model, what mediates upregulation of
PDK4 gene expression and whether increased mitochon-
drial fatty acid oxidation is directly caused by upregulated
PDK4.
In summary, transgenic expression of DGAT1 in skeletal
muscle results in a series of “paradoxical” metabolic
changes often seen in the exercise-trained muscle, includ-
ing increased triglyceride synthesis, increased fatty acid
oxidation, and preserved insulin sensitivity during the
challenging of fat overload. Although a high triglyceride
content and PDK4 expression level may serve as markers
of insulin resistance in sedentary and obese individuals,
the same parameters may reﬂect a greater capacity for
fat metabolism. In the latter situation, insulin sensitivity
is preserved because of reduced levels of intracellular
fatty acid derivatives. Because DGAT1 is induced in exer-
cise, and because the MCK-DGAT1 model presents a set of
metabolic features similar to the exercise model, we
hypothesize that DGAT1 mediates a signiﬁcant part of
exercise-induced metabolic remodeling in skeletal muscle.
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